Humana Inc. has finalized the sale of a 60% stake in its Kindred at Home hospice and personal care divisions to Clayton, Dubilier & Rice for $2.8 billion, a move intended to enhance its financial positioning. The company plans to utilize the sale proceeds for debt repayment and share buybacks, despite a 1.1% decline in shares year-to-date. Humana has maintained strong revenue growth with $83.1 billion reported, and analysts expect quarterly earnings of $6.79 per share, indicating confidence in its operational performance.
“Humana Inc. · has a trailing four-quarter earnings surprise of · 3.10% · on average”
“Humana Inc. · is one of the largest · health care plan providers in the United States”
“Year to date · shares of Humana · have lost · 1.1%”
“Humana · posted · revenue · $83.1 billion”
“Humana · equates to · growth rate · 7.7% year-over-year”
“Humana · recorded · non-GAAP diluted earnings per share growth · healthy”
“Humana Inc · has agreed to divest · a majority interest in the Hospice and Personal Care divisions · to Clayton, Dubilier & Rice”
“Humana · will divest · a 60% interest in KAH Hospice · approximately $2.8 billion”
“Humana · will use the proceeds · to repay debt and share repurchases”
“Humana Inc. · is scheduled to release · first-quarter 2022 earnings · on Apr 27, before the opening bell”
“Humana · boasts · an impressive earnings surprise history · .”
“Humana · beat estimates · in each of the trailing four quarters · with an average surprise of 3.10%”
